<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">PKJSxKSK44rrX6mzrDY8b3r</article-id>
      <article-id pub-id-type="other">00007</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010001100007</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09500107</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010005000071</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo Original</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Morbimortalidade em octogen&#225;rios submetidos &#224; cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pivatto J&#250;nior</surname>
            <given-names>Fernando</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kalil</surname>
            <given-names>Renato A. K.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Costa</surname>
            <given-names>Altamiro R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pereira</surname>
            <given-names>Edemar M. C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santos</surname>
            <given-names>Eduardo Z.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Valle</surname>
            <given-names>Felipe H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bender</surname>
            <given-names>Luciano P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Trombka</surname>
            <given-names>Marcelo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Modkovski</surname>
            <given-names>Tha&#237;s B.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nesralla</surname>
            <given-names>Ivo A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Porto Alegre</named-content>
          <named-content content-type="state">Rio Grande do Sul</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de Ci&#234;ncias da Sa&#250;de de Porto Alegre</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff01">
        <institution content-type="orgname">Instituto de Cardiologia do Rio Grande do Sul/FUC</institution>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>07</month>
        <year>2010</year>
      </pub-date>
      <volume>95</volume>
      <issue>1</issue>
      <fpage>41</fpage>
      <lpage>46</lpage>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>05</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>06</day>
          <month>08</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>09</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: O progressivo aumento da longevidade da popula&#231;&#227;o tem levado cada vez mais pacientes octogen&#225;rios a necessitarem de cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica (CRM), sendo necess&#225;rio conhecer os riscos e benef&#237;cios desse procedimento nessa faixa et&#225;ria. OBJETIVO: Descrever a morbimortalidade hospitalar de pacientes com idade igual ou superior a 80 anos submetidos &#224; CRM e identificar vari&#225;veis que se constituem em seus preditores. M&#201;TODOS: Foram estudados 140 casos consecutivos entre janeiro de 2002 e dezembro de 2007. Os pacientes possu&#237;am em m&#233;dia 82,5 &#177; 2,2 anos (80-89), e 55,7% eram do sexo masculino. Na amostra, 72,9% tinham hipertens&#227;o arterial, 26,4% diabete, 65,7% les&#227;o grave em tr&#234;s ou mais vasos e 28,6% em tronco da coron&#225;ria esquerda. Cirurgia associada esteve presente em 35,7% dos pacientes, sendo a valvar a&#243;rtica em 26,4% e a mitral em 5,6%. RESULTADOS: A mortalidade foi de 14,3% (CRM isolada 10,0% x 22,0% associada; p = 0,091) e a morbidade de 37,9% (CRM isolada 34,4% x 44,0% associada; p = 0,35). Complica&#231;&#245;es mais frequentes: baixo d&#233;bito card&#237;aco (27,9%), disfun&#231;&#227;o renal (10,0%) e suporte ventilat&#243;rio prolongado (9,6%). Na an&#225;lise bivariada, os maiores preditores de mortalidade foram sepse (RR 10,2 IC 95%: 6,10-17,7), CRM pr&#233;via (RR 8,06 IC 95%: 5,16-12,6), baixo d&#233;bito card&#237;aco p&#243;s-operat&#243;rio (RR 7,77 IC 95%: 3,03-19,9) e disfun&#231;&#227;o renal p&#243;s-operat&#243;ria (RR 7,36 IC 95%: 3,71-14,6). Quanto &#224; morbidade, foram preditores tempo de circula&#231;&#227;o extracorp&#243;rea &gt;120 min. (RR: 2,34 IC 95%: 1,62-3,38) e de isquemia &gt; 90 min. (RR: 2,29 IC 95%: 1,56-3,37). CONCLUS&#195;O: A CRM em octogen&#225;rios est&#225; relacionada a uma morbimortalidade maior do que nos pacientes mais jovens, o que, entretanto, n&#227;o impede a interven&#231;&#227;o se houver indica&#231;&#227;o pela condi&#231;&#227;o cl&#237;nica.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Revasculariza&#231;&#227;o mioc&#225;rdica</kwd>
        <kwd>mortalidade</kwd>
        <kwd>morbidade</kwd>
        <kwd>idoso de 80 anos ou mais</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>18</day>
        <month>06</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>ARTIGO ORIGINAL</bold>
    </p>
    <p>
      <bold>CIRURGIA CARD&#205;ACA - ADULTOS</bold>
    </p>
    <p>
      <bold>Morbimortalidade em octogen&#225;rios submetidos &#224; cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica</bold>
    </p>
    <p>
      <bold>Fernando Pivatto J&#250;nior<sup>I,II</sup>; Renato A. K. Kalil<sup>I,II</sup>; Altamiro R. Costa<sup>I</sup>; Edemar M. C. Pereira<sup>I,II</sup>; Eduardo Z. Santos<sup>I,II</sup>; Felipe H. Valle<sup>I,II</sup>; Luciano P. Bender<sup>I,II</sup>; Marcelo Trombka<sup>I,II</sup>; Tha&#237;s B. Modkovski<sup>I,II</sup>; Ivo A. Nesralla<sup>I</sup></bold>
    </p>
    <p><sup>I</sup>Instituto de Cardiologia do Rio Grande do Sul/FUC - IC-FUC </p>
    <p><sup>II</sup>Universidade Federal de Ci&#234;ncias da Sa&#250;de de Porto Alegre - UFCSPA, Porto Alegre, RS - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="endb">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> O progressivo aumento da longevidade da popula&#231;&#227;o tem levado cada vez mais pacientes octogen&#225;rios a necessitarem de cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica (CRM), sendo necess&#225;rio conhecer os riscos e benef&#237;cios desse procedimento nessa faixa et&#225;ria. </p>
    <p><bold>OBJETIVO:</bold> Descrever a morbimortalidade hospitalar de pacientes com idade igual ou superior a 80 anos submetidos &#224; CRM e identificar vari&#225;veis que se constituem em seus preditores. </p>
    <p><bold>M&#201;TODOS:</bold> Foram estudados 140 casos consecutivos entre janeiro de 2002 e dezembro de 2007. Os pacientes possu&#237;am em m&#233;dia 82,5 &#177; 2,2 anos (80-89), e 55,7% eram do sexo masculino. Na amostra, 72,9% tinham hipertens&#227;o arterial, 26,4% diabete, 65,7% les&#227;o grave em tr&#234;s ou mais vasos e 28,6% em tronco da coron&#225;ria esquerda. Cirurgia associada esteve presente em 35,7% dos pacientes, sendo a valvar a&#243;rtica em 26,4% e a mitral em 5,6%. </p>
    <p><bold>RESULTADOS:</bold> A mortalidade foi de 14,3% (CRM isolada 10,0% x 22,0% associada; p = 0,091) e a morbidade de 37,9% (CRM isolada 34,4% x 44,0% associada; p = 0,35). Complica&#231;&#245;es mais frequentes: baixo d&#233;bito card&#237;aco (27,9%), disfun&#231;&#227;o renal (10,0%) e suporte ventilat&#243;rio prolongado (9,6%). Na an&#225;lise bivariada, os maiores preditores de mortalidade foram sepse (RR 10,2 IC 95%: 6,10-17,7), CRM pr&#233;via (RR 8,06 IC 95%: 5,16-12,6), baixo d&#233;bito card&#237;aco p&#243;s-operat&#243;rio (RR 7,77 IC 95%: 3,03-19,9) e disfun&#231;&#227;o renal p&#243;s-operat&#243;ria (RR 7,36 IC 95%: 3,71-14,6). Quanto &#224; morbidade, foram preditores tempo de circula&#231;&#227;o extracorp&#243;rea <underline>&gt;</underline>120 min. (RR: 2,34 IC 95%: 1,62-3,38) e de isquemia <underline>&gt;</underline> 90 min. (RR: 2,29 IC 95%: 1,56-3,37). </p>
    <p><bold>CONCLUS&#195;O:</bold> A CRM em octogen&#225;rios est&#225; relacionada a uma morbimortalidade maior do que nos pacientes mais jovens, o que, entretanto, n&#227;o impede a interven&#231;&#227;o se houver indica&#231;&#227;o pela condi&#231;&#227;o cl&#237;nica. </p>
    <p><bold>Palavras-chave:</bold> Revasculariza&#231;&#227;o mioc&#225;rdica, mortalidade, morbidade, idoso de 80 anos ou mais.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>Nos &#250;ltimos anos, a popula&#231;&#227;o de pacientes idosos tem aumentado de maneira consider&#225;vel, tanto nos pa&#237;ses desenvolvidos como tamb&#233;m nos pa&#237;ses considerados em desenvolvimento<sup>1</sup>. Os dados demogr&#225;ficos brasileiros apontam um evidente aumento dessa popula&#231;&#227;o, com estimativas colocando o Brasil como a sexta popula&#231;&#227;o de idosos do mundo em 2025<sup>2</sup>.</p>
    <p>A doen&#231;a cardiovascular &#233; extremamente prevalente nessa faixa et&#225;ria, com aproximadamente 40% dos octogen&#225;rios apresentando doen&#231;a cardiovascular sintom&#225;tica<sup>3</sup>. Diversos modelos de estudo epidemiol&#243;gico preveem que, com as atuais taxas de crescimento da popula&#231;&#227;o idosa, haver&#225; n&#227;o s&#243; um aumento na incid&#234;ncia da doen&#231;a arterial coronariana, mas tamb&#233;m na mortalidade total e no custo econ&#244;mico, devendo-se ter, provavelmente, nas pr&#243;ximas d&#233;cadas, um aumento progressivo do n&#250;mero de pacientes idosos que se apresentam aos servi&#231;os de cirurgia card&#237;aca<sup>4</sup>.</p>
    <p>Atualmente, &#233; habitual a indica&#231;&#227;o de cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica (CRM) em septuagen&#225;rios, o que se torna cada vez mais comum em octogen&#225;rios e n&#227;o raro em nonagen&#225;rios<sup>5</sup>. A idade avan&#231;ada tem sido vastamente mostrada na literatura como uma vari&#225;vel correlacionada com a mortalidade operat&#243;ria: por diversas raz&#245;es, ela pode ser considerada como fator de alto risco em procedimentos cir&#250;rgicos de grande porte, especialmente em cirurgias card&#237;acas<sup>4</sup>. </p>
    <p>A mortalidade operat&#243;ria em pacientes com idade igual ou superior a 70 anos variou de 5 a 20% nos &#250;ltimos 20 anos para CRM isolada, sendo em m&#233;dia de 8,9%<sup>6</sup>. A Diretriz da ACC/AHA refere mortalidade de 5,28% acima dos 75 anos e de 8,38% acima dos 80 anos<sup>6</sup>.</p>
    <p>Este trabalho teve como objetivo principal descrever a morbimortalidade hospitalar de pacientes octogen&#225;rios submetidos &#224; CRM e, secundariamente, identificar vari&#225;veis pr&#233;, trans e p&#243;s-operat&#243;rias preditoras de morbidade e/ou mortalidade.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Este estudo retrospectivo abrangeu todos os pacientes consecutivos com idade igual ou superior a 80 anos submetidos &#224; CRM no per&#237;odo de janeiro de 2002 a dezembro de 2007 no Instituto de Cardiologia do Rio Grande do Sul. As vari&#225;veis inclu&#237;das neste estudo est&#227;o descritas na <xref ref-type="table" rid="tab1">Tabela 1</xref>. </p>
    <table-wrap id="tab1">
      <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt01.jpg"/></table-wrap>
    <p>A disfun&#231;&#227;o renal, tanto pr&#233; como p&#243;s-operat&#243;ria, foi definida pelo n&#237;vel s&#233;rico de creatinina superior a 2 mg/ml. A classifica&#231;&#227;o de insufici&#234;ncia card&#237;aca seguiu os crit&#233;rios estabelecidos pela <italic>New York Heart Association</italic> (NYHA). Foi considerada les&#227;o coronariana grave se superior a 70% nas art&#233;rias coron&#225;rias ou a 50% no tronco da coron&#225;ria esquerda (TCE). A fra&#231;&#227;o de eje&#231;&#227;o foi considerada baixa quando menor que 50% e normal se superior a esse valor. Baixo d&#233;bito card&#237;aco foi considerado toda instabilidade hemodin&#226;mica com necessidade de drogas vasoativas ou de bal&#227;o intra-a&#243;rtico. Altera&#231;&#245;es neurol&#243;gicas localizadas ou altera&#231;&#245;es do n&#237;vel de consci&#234;ncia por um per&#237;odo superior a 24 horas foram definidas como acidente vascular cerebral. Mortalidade hospitalar foi definida como qualquer &#243;bito durante a interna&#231;&#227;o do paciente, independente de sua dura&#231;&#227;o. A ocorr&#234;ncia de qualquer um destes eventos no p&#243;s-operat&#243;rio foi definida como morbidade operat&#243;ria: baixo d&#233;bito card&#237;aco, uso do bal&#227;o intra-a&#243;rtico, sepse, infec&#231;&#227;o da ferida operat&#243;ria ou do membro inferior, disfun&#231;&#227;o renal, acidente vascular cerebral, reinterven&#231;&#227;o por sangramento e tempo do suporte ventilat&#243;rio prolongado, superior a 48 horas. </p>
    <p>Visto a estrutura retrospectiva deste estudo, houve perda, j&#225; esperada, de alguns dados ausentes nos prontu&#225;rios. Isso ocorreu com mais frequ&#234;ncia nas vari&#225;veis classe funcional NYHA, fra&#231;&#227;o de eje&#231;&#227;o, tempo de circula&#231;&#227;o extracorp&#243;rea, de isquemia e de suporte ventilat&#243;rio.</p>
    <p>Os dados foram coletados diretamente a partir dos prontu&#225;rios, sendo inseridos e analisados no <italic>software</italic> SPSS 15.0. A an&#225;lise descritiva para as vari&#225;veis qualitativas foi realizada a partir da distribui&#231;&#227;o de frequ&#234;ncia absoluta e relativa, e para as quantitativas atrav&#233;s da m&#233;dia e desvio-padr&#227;o. A fim de avaliar estatisticamente a associa&#231;&#227;o entre duas vari&#225;veis qualitativas foi utilizado o teste do qui-quadrado ou exato de Fisher quando indicado. Para comparar a m&#233;dia das vari&#225;veis quantitativas em rela&#231;&#227;o &#224; mortalidade foi utilizado o teste <italic>t</italic> de <italic>Student</italic>. Para avaliar a associa&#231;&#227;o entre o risco de mortalidade e as vari&#225;veis foi utilizada a regress&#227;o de Poisson. O n&#237;vel de signific&#226;ncia adotado em todos os testes foi de 5%. Em fun&#231;&#227;o da baixa mortalidade encontrada e da presen&#231;a de diversas vari&#225;veis significativas na an&#225;lise de regress&#227;o bruta de Poisson, n&#227;o foi realizada a an&#225;lise multivariada.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>A amostra obtida foi de 140 pacientes, em um universo de 4.203 revasculariza&#231;&#245;es cir&#250;rgicas (3,3%), sendo 78 (55,5%) masculinos. A idade dos pacientes variou de 80 a 89 anos, com uma m&#233;dia de 82,5 &#177; 2,2. As caracter&#237;sticas da popula&#231;&#227;o est&#227;o descritas na <xref ref-type="table" rid="tab2">Tabela 2</xref>. </p>
    <table-wrap id="tab2">
      <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt02.jpg"/></table-wrap>
    <p>Em rela&#231;&#227;o aos dados cir&#250;rgicos, todos os procedimentos foram realizados com circula&#231;&#227;o extracorp&#243;rea. A art&#233;ria mam&#225;ria interna foi utilizada em 24,3% dos pacientes, a m&#233;dia de tempo da circula&#231;&#227;o extracorp&#243;rea foi 85,4 &#177; 28,8 minutos e o de isquemia mioc&#225;rdica 58,0 &#177; 22,3 minutos. Cirurgia associada foi realizada em 50 (35,7%) pacientes. Os procedimentos associados est&#227;o listados na <xref ref-type="table" rid="tab3">Tabela 3</xref>.</p>
    <table-wrap id="tab3">
      <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt03.jpg"/></table-wrap>
    <p>Cinquenta e tr&#234;s pacientes (37,9%) apresentaram ao menos uma complica&#231;&#227;o no per&#237;odo p&#243;s-operat&#243;rio. Nos pacientes com revasculariza&#231;&#227;o isolada, a taxa de complica&#231;&#245;es foi de 34,4%, n&#227;o havendo diferen&#231;a significativa ao compararmos com o grupo submetido a outro procedimento associado (44,0%; p = 0,35).</p>
    <p>A <xref ref-type="table" rid="tab4">Tabela 4</xref> mostra a preval&#234;ncia das complica&#231;&#245;es p&#243;s-operat&#243;rias analisadas, sendo poss&#237;vel observar que o baixo d&#233;bito card&#237;aco foi a intercorr&#234;ncia mais comum (27,9%). </p>
    <table-wrap id="tab4">
      <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt04.jpg"/></table-wrap>
    <p>A mortalidade hospitalar foi de 14,3% (20 pacientes), sendo de 10% nos pacientes submetidos &#224; revasculariza&#231;&#227;o isolada e de 22% nos submetidos a outro procedimento associado: essa diferen&#231;a n&#227;o foi estatisticamente significativa (p = 0,091). Choque cardiog&#234;nico foi a principal causa de &#243;bito encontrada, sendo respons&#225;vel pelo falecimento de 11 (55,0%) pacientes.</p>
    <p>Os fatores de risco para mortalidade hospitalar est&#227;o descritos na <xref ref-type="table" rid="aop06910a05tab05m">Tabela 5</xref>. Os demais fatores analisados n&#227;o se mostraram significativos em an&#225;lise bivariada. </p>
    <p content-type="asset">
      <table-wrap id="aop06910a05tab05m">
        <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt05.jpg"/></table-wrap>
    </p>
    <p>Em rela&#231;&#227;o aos preditores de morbidade, apenas os tempos de circula&#231;&#227;o extracorp&#243;rea e de isquemia prolongados mostraram-se estatisticamente significativos (<xref ref-type="table" rid="aop06910a05tab06m">Tabela 6</xref>). </p>
    <p content-type="asset">
      <table-wrap id="aop06910a05tab06m">
        <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt06.jpg"/></table-wrap>
    </p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Com crescente frequ&#234;ncia ocorre a necessidade de decis&#227;o sobre o melhor tratamento da doen&#231;a arterial coronariana em pacientes com mais de 80 anos. O envelhecimento promove o aumento de comorbidades, al&#233;m do aumento da preval&#234;ncia de doen&#231;a arterial coronariana e de suas consequ&#234;ncias nos mais idosos<sup>7</sup>.</p>
    <p>A indica&#231;&#227;o cir&#250;rgica nos pacientes octogen&#225;rios visa, principalmente, ao al&#237;vio dos sintomas e a uma melhora na qualidade de vida, uma vez que o resultado a longo prazo est&#225; limitado pela expectativa de vida nessa faixa et&#225;ria e ainda pode ser afetado pelo surgimento, em outros &#243;rg&#227;os, de doen&#231;as relativas &#224; pr&#243;pria idade<sup>1</sup>. Nos &#250;ltimos anos, a CRM tem sido executada em pacientes cada vez mais idosos, com envolvimento multivascular coron&#225;rio, disfun&#231;&#227;o ventricular esquerda e outras afec&#231;&#245;es cr&#244;nico-degenerativas associadas. As caracter&#237;sticas da popula&#231;&#227;o deste estudo comprovam tais peculiaridades, na medida em que 65,7% dos pacientes possu&#237;am les&#227;o grave triarterial, 26,4% diabete e 72,9% hipertens&#227;o e 26,4% diabete, frequ&#234;ncias semelhantes aos dados da literatura<sup>8-10</sup>. Tal fato representa uma caracter&#237;stica importante dessa popula&#231;&#227;o, a qual contribui para o aumento de seu risco cir&#250;rgico. </p>
    <p>A combina&#231;&#227;o de doen&#231;a coronariana mais avan&#231;ada e de piores comorbidades ocasiona um aumento de complica&#231;&#245;es fatais e n&#227;o fatais, com maiores taxas de infarto do mioc&#225;rdio intra ou p&#243;s-operat&#243;rio, baixo d&#233;bito card&#237;aco, acidente vascular cerebral, complica&#231;&#245;es gastrointestinais, infec&#231;&#227;o da ferida operat&#243;ria, insufici&#234;ncia renal e uso do bal&#227;o intra-a&#243;rtico<sup>6</sup>. No presente estudo, a complica&#231;&#227;o mais frequente foi o baixo d&#233;bito card&#237;aco (27,9%), como ocorreu tamb&#233;m em outras s&#233;ries<sup>4,11</sup>. </p>
    <p>A mortalidade hospitalar de 14,3% desta s&#233;rie de casos encontra concord&#226;ncia com a literatura. No mesmo per&#237;odo deste levantamento, foram realizadas no Instituto de Cardiologia 3.530 cirurgias de revasculariza&#231;&#227;o isolada, com mortalidade hospitalar global de 3,7%, e 673 revasculariza&#231;&#245;es com cirurgias associadas, cuja mortalidade foi de 10,3%. A distin&#231;&#227;o das taxas de mortalidade do procedimento isolado (10%) e do associado a outro procedimento &#233; relevante, visto que &#233; sabido que a realiza&#231;&#227;o da cirurgia associada incrementa o risco de mortalidade. Igl&#233;zias e cols.<sup>12</sup> demonstraram um aumento de 25% na mortalidade hospitalar, com diferen&#231;a estatisticamente significativa (p = 0,002) para o grupo que realizou cirurgia isolada, diferentemente do que ocorreu na presente pesquisa.</p>
    <p>L&#243;pez-Rodr&#237;guez e cols.<sup>13</sup>, em an&#225;lise recente de 140 octogen&#225;rios submetidos &#224; cirurgia card&#237;aca, encontraram uma mortalidade de 8,3% na cirurgia isolada e de 21,4% na associada, sendo que nesse estudo a circula&#231;&#227;o extracorp&#243;rea n&#227;o foi utilizada em 25% dos pacientes. Peterson e cols.<sup>14</sup> realizaram o maior estudo com pacientes octogen&#225;rios at&#233; o presente momento, incluindo 24.461 pacientes submetidos &#224; cirurgia isolada, descrevendo uma mortalidade hospitalar de 11,5%. </p>
    <p>V&#225;rios trabalhos t&#234;m relatado os resultados da CRM em idosos, por se tratar de um grupo diferente de pacientes principalmente em rela&#231;&#227;o &#224;s associa&#231;&#245;es com outras doen&#231;as no pr&#233;-operat&#243;rio e &#224;s complica&#231;&#245;es que podem aparecer ap&#243;s o procedimento<sup>15</sup>. Entretanto, at&#233; o presente momento, h&#225; poucos estudos no cen&#225;rio nacional que abordam os pacientes octogen&#225;rios, sendo essa a contribui&#231;&#227;o deste artigo.</p>
    <p>Igl&#233;zias e cols.<sup>4</sup> analisaram 361 pacientes com idade igual ou superior a 70 anos (m&#233;dia 73,9 &#177; 3,3) submetidos &#224; CRM isolada, descrevendo uma mortalidade de 9,1% em 30 dias. Esse mesmo grupo analisou, em outro estudo<sup>11</sup>, 100 pacientes submetidos &#224; CRM isolada com idade tamb&#233;m igual ou maior a 70 anos, sendo metade operados com circula&#231;&#227;o extracorp&#243;rea (CEC) e a outra metade sem essa t&#233;cnica, tendo ambos os grupos m&#233;dia de idade superior a 75 anos. A sobrevida em 30 dias foi de 92% para os operados com CEC e de 96% para os operados sem CEC, n&#227;o havendo diferen&#231;a estatisticamente significativa.</p>
    <p>Em rela&#231;&#227;o aos procedimentos cir&#250;rgicos deste estudo, como j&#225; descrito, todos foram realizados utilizando CEC. Os benef&#237;cios da realiza&#231;&#227;o de cirurgias card&#237;acas sem CEC (<italic>off-pump)</italic> em idosos t&#234;m sido motivo de discuss&#227;o h&#225; algum tempo. Em artigo recente, cujo objetivo foi comparar os resultados da CRM sem CEC em octogen&#225;rios com a cirurgia convencional, n&#227;o foi observada diferen&#231;a estatisticamente significativa na mortalidade entre esses dois grupos (convencional 6,7%<italic> vs</italic> 3,1%; p = 0,22)<sup>16</sup>. Li e cols.<sup>17</sup>, em an&#225;lise de 1.191 pacientes com idade superior a 65 anos, observaram que a CRM sem CEC esteve associada com desfechos precoces mais favor&#225;veis, os quais, entretanto, n&#227;o se mantiveram no seguimento, sendo a cirurgia tradicional relacionada a melhores resultados a m&#233;dio e longo prazo. Essa observa&#231;&#227;o foi ratificada em artigo de revis&#227;o recente, no qual foi observado que as evid&#234;ncias atuais sugerem que a CRM sem CEC pode oferecer uma menor morbidade perioperat&#243;ria, mas ao custo de uma menor efetividade a longo prazo<sup>18</sup>.</p>
    <p>A art&#233;ria tor&#225;cica interna (ATI) &#233; o melhor enxerto para revasculariza&#231;&#227;o mioc&#225;rdica em termos de pat&#234;ncia a longo prazo, livre recorr&#234;ncia de angina e de eventos card&#237;acos tardios. Devido ao aparente benef&#237;cio da utiliza&#231;&#227;o da ATI ter sido mais enfatizado quanto aos resultados tardios de pat&#234;ncia e sobrevida, muitos cirurgi&#245;es evitavam seu uso em pacientes idosos, assumindo n&#227;o estar acrescentando substancial benef&#237;cio a essa popula&#231;&#227;o<sup>19</sup>. No Brasil, a expectativa de vida atual &#233; de 72,4 anos; por&#233;m os indiv&#237;duos que atingem a idade de 80 anos t&#234;m em m&#233;dia mais 9,4 anos de sobrevida<sup>20</sup>. Portanto, mais importante que a expectativa de vida global da popula&#231;&#227;o geral &#233; a expectativa de quem atinge os 80 anos. Em rela&#231;&#227;o aos pacientes octogen&#225;rios submetidos &#224; CRM isolada, estudos j&#225; demonstraram uma sobrevida semelhante<sup>14</sup> ou mesmo superior<sup>21</sup> &#224; da popula&#231;&#227;o geral. Portanto, a n&#227;o utiliza&#231;&#227;o da ATI no idoso, devido &#224; presumida perda de import&#226;ncia da sua pat&#234;ncia tardia, n&#227;o pode ser vista como correta.</p>
    <p>A baixa taxa de utiliza&#231;&#227;o da ATI neste estudo (24,3%) justifica-se pelo seu car&#225;ter retrospectivo, no qual se verificou a realidade de um hospital por um longo per&#237;odo de tempo, onde a opini&#227;o do uso desse enxerto na faixa et&#225;ria em quest&#227;o modificou-se, sendo a prefer&#234;ncia atual da maioria dos cirurgi&#245;es o implante de mam&#225;rias mesmo nos octogen&#225;rios.</p>
    <p>Os preditores de mortalidade hospitalar mostrados na <xref ref-type="table" rid="tab4">Tabela 4</xref> s&#227;o semelhantes aos encontrados em outros estudos em idosos. Os preditores mais significativos foram sepse, CRM pr&#233;via, baixo d&#233;bito card&#237;aco p&#243;s-operat&#243;rio e disfun&#231;&#227;o renal, tanto pr&#233; como p&#243;s-operat&#243;ria. &#201; importante ressaltar novamente a limita&#231;&#227;o deste estudo pela impossibilidade de, em virtude da reduzida amostra e do grande n&#250;mero de vari&#225;veis preditoras significativas em an&#225;lise bivariada, realizar uma an&#225;lise multivariada, na qual poderiam ser obtidas indica&#231;&#245;es de preditores independentes de mortalidade hospitalar. </p>
    <p>Em an&#225;lise de 589 pacientes com idade superior a 75 anos submetidos &#224; cirurgia card&#237;aca, L&#243;pez-Rodr&#237;guez e cols.<sup>13</sup> verificaram o tempo de circula&#231;&#227;o extracorp&#243;rea prolongado, superior a 120 minutos, como preditor independente de morbidade p&#243;s-operat&#243;ria. No presente estudo, essa vari&#225;vel mostrou-se preditora em an&#225;lise bivariada, assim como o tempo de isquemia prolongado.</p>
    <p>Segundo as Diretrizes da Sociedade Brasileira de Cardiologia<sup>22</sup>, a idade n&#227;o deve ser contraindica&#231;&#227;o para a realiza&#231;&#227;o da cirurgia, sendo importante avaliar a idade real com a aparente, o estado geral e as capacidades f&#237;sicas e intelectuais do paciente. De acordo com as Diretrizes da ACC/AHA<sup>6</sup>, o paciente e o m&#233;dico devem juntos explorar os potenciais benef&#237;cios da melhora da qualidade de vida, observando os riscos do procedimento em compara&#231;&#227;o com uma terapia alternativa, tamb&#233;m levando em conta a capacidade funcional basal e a prefer&#234;ncia do paciente. A idade isoladamente n&#227;o deve ser uma contraindica&#231;&#227;o para a CRM, se considerarmos que os benef&#237;cios superam o risco do procedimento a longo prazo.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>A CRM em octogen&#225;rios est&#225; relacionada a uma morbimortalidade maior do que em pacientes mais jovens, o que, entretanto, n&#227;o impede a interven&#231;&#227;o se houver indica&#231;&#227;o pela condi&#231;&#227;o cl&#237;nica. As complica&#231;&#245;es mais frequentes foram baixo d&#233;bito card&#237;aco, disfun&#231;&#227;o renal e suporte ventilat&#243;rio prolongado. Os maiores preditores de mortalidade foram sepse, CRM pr&#233;via, baixo d&#233;bito card&#237;aco p&#243;s-operat&#243;rio e disfun&#231;&#227;o renal p&#243;s-operat&#243;ria. Quanto &#224; morbidade, foram preditores tempo de circula&#231;&#227;o extracorp&#243;rea <underline>&gt;</underline> 120 min. e de isquemia <underline>&gt;</underline> 90 min. Assim, a indica&#231;&#227;o de cirurgia deve ser criteriosamente avaliada e individualizada, levando-se em considera&#231;&#227;o a idade e estado geral do paciente, sua expectativa de vida, sua probabilidade de retorno &#224; vida social, a localiza&#231;&#227;o e gravidade das les&#245;es coronarianas, a extens&#227;o do mioc&#225;rdio sob isquemia, a intensidade dos sintomas, a presen&#231;a de comorbidades, a experi&#234;ncia da equipe cir&#250;rgica e os resultados comparativos com as outras formas de tratamento, seja farmacol&#243;gico ou atrav&#233;s da angioplastia percut&#226;nea.</p>
    <p>
      <bold>Agradecimentos</bold>
    </p>
    <p>Agradecimentos aos doutores Guaracy Fernandes Teixeira Filho, Paulo Roberto Prates e Jo&#227;o Ricardo Michielin Sant&#180;Anna, membros da Equipe de Cirurgia Cardiovascular do IC-FUC.</p>
    <p>
      <fn id="endb" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Renato A. K. Kalil </p>
        <p> Av. Princesa Isabel, 370 - Santana </p>
        <p> 90.620-001 - Porto Alegre,RS - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="kalil.pesquisa@cardiologia.org.br">kalil.pesquisa@cardiologia.org.br</email>, </p>
        <p>
          <email xlink:href="fpivatto@gmail.com">fpivatto@gmail.com</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 05/11/08; revisado recebido em 06/08/09; aceito em 25/09/09.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Lima R, Diniz R, C&#233;sio A, Vasconcelos F, Gesteira M, Menezes A, et al. Revasculariza&#231;&#227;o mioc&#225;rdica em pacientes octogen&#225;rios: estudo retrospectivo e comparativo entre pacientes operados com e sem circula&#231;&#227;o extracorp&#243;rea. Rev Bras Cir Cardiovasc. 2005; 20 (1): 8-13.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Revasculariza&#231;&#227;o mioc&#225;rdica em pacientes octogen&#225;rios: estudo retrospectivo e comparativo entre pacientes operados com e sem circula&#231;&#227;o extracorp&#243;rea</article-title>
          <source>Rev Bras Cir Cardiovasc.</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>8</fpage>
          <lpage>13</lpage>
          <issue>1</issue>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lima</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Diniz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>C&#233;sio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vasconcelos</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gesteira</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Menezes</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Whitaker JF, Passos PHC, Ramalho GM, Muniz AJ, Pimentel RC, Loures JBL, et al. Utiliza&#231;&#227;o da art&#233;ria radial como segundo enxerto arterial em pacientes acima de 70 anos. Rev Bras Cir Cardiovasc. 2005; 20 (1): 58-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Utiliza&#231;&#227;o da art&#233;ria radial como segundo enxerto arterial em pacientes acima de 70 anos</article-title>
          <source>Rev Bras Cir Cardiovasc.</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>58</fpage>
          <lpage>62</lpage>
          <issue>1</issue>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Whitaker</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Passos</surname>
              <given-names>PHC</given-names>
            </name>
            <name>
              <surname>Ramalho</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Muniz</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Pimentel</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Loures</surname>
              <given-names>JBL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Loures DRR, Carvalho RG, Mulinari L, Silva Jr AZ, Schmidlin CA, Brommelstr&#246;et M, et al. Cirurgia card&#237;aca no idoso. Rev Bras Cir Cardiovasc. 2000; 15 (1): 1-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cirurgia card&#237;aca no idoso</article-title>
          <source>Rev Bras Cir Cardiovasc.</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1</fpage>
          <lpage>5</lpage>
          <issue>1</issue>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Loures</surname>
              <given-names>DRR</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Mulinari</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>Jr AZ</given-names>
            </name>
            <name>
              <surname>Schmidlin</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Brommelstr&#246;et</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Igl&#233;zias JCR, Oliveira Jr. JL, Dallan LAO, Louren&#231;&#227;o Jr A, Stolf NAG. Preditores de mortalidade hospitalar no paciente idoso portador de doen&#231;a arterial coron&#225;ria. Rev Bras Cir Cardiovasc. 2001; 16 (2): 94-104.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Preditores de mortalidade hospitalar no paciente idoso portador de doen&#231;a arterial coron&#225;ria</article-title>
          <source>Rev Bras Cir Cardiovasc.</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>94</fpage>
          <lpage>104</lpage>
          <issue>2</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Igl&#233;zias</surname>
              <given-names>JCR</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>Jr. JL</given-names>
            </name>
            <name>
              <surname>Dallan</surname>
              <given-names>LAO</given-names>
            </name>
            <name>
              <surname>Louren&#231;&#227;o</surname>
              <given-names>Jr A</given-names>
            </name>
            <name>
              <surname>Stolf</surname>
              <given-names>NAG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Kalil RAK. Consensos e controv&#233;rsias na doen&#231;a arterial coronariana cr&#244;nica: quando indicar a cirurgia? Revista da Sociedade de Cardiologia do Rio Grande do Sul, 2008; 13: 1-3.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Consensos e controv&#233;rsias na doen&#231;a arterial coronariana cr&#244;nica: quando indicar a cirurgia</article-title>
          <source>Revista da Sociedade de Cardiologia do Rio Grande do Sul,</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1</fpage>
          <lpage>3</lpage>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kalil</surname>
              <given-names>RAK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Eagle KA, Guyton RA, Davidoff R, Eduwards FH, Ewy GA, Gardner TJ, et al. ACC / AHA 2004 guideline update for coronary artery bypass graft surgery: a report ACC/AHA Task Force on Practice Guideline. Circulation. 2004; 110 (14): e340-437.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>ACC / AHA 2004 guideline update for coronary artery bypass graft surgery: a report ACC/AHA Task Force on Practice Guideline</article-title>
          <source>Circulation.</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>e340</fpage>
          <lpage>437</lpage>
          <issue>14</issue>
          <volume>110</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Eagle</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Guyton</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Davidoff</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Eduwards</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Ewy</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Wajngarten M, Oliveira SA. Doen&#231;a coronariana no grande idoso: conduta conservadora ou agressiva? Arq Bras Cardiol. 2003; 81(3): 219-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Doen&#231;a coronariana no grande idoso: conduta conservadora ou agressiva</article-title>
          <source>Arq Bras Cardiol.</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>219</fpage>
          <lpage>20</lpage>
          <issue>3</issue>
          <volume>81</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wajngarten</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Nagano N, Kohmoto T, Hirose H, Amano A, Yoshida S, Takahashi A. Coronary artery bypass grafting in the elderly. Chest. 2000; 117: 1262-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary artery bypass grafting in the elderly</article-title>
          <source>Chest.</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1262</fpage>
          <lpage>70</lpage>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nagano</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kohmoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hirose</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Amano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Bardakci H, Cheema FH, Topkara VK, Dang NC, Martens TP, Mercando ML, et al. Discharge to home rates are significantly lower for octogenarians undergoing coronary artery bypass graft surgery. Ann Thorac Surg. 2007; 83: 483-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Discharge to home rates are significantly lower for octogenarians undergoing coronary artery bypass graft surgery</article-title>
          <source>Ann Thorac Surg.</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>483</fpage>
          <lpage>9</lpage>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bardakci</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cheema</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Topkara</surname>
              <given-names>VK</given-names>
            </name>
            <name>
              <surname>Dang</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Martens</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Mercando</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Peterson ED, Alexander KP, Malenka DJ, Hannan EL, O'Conner GT, McCallister BD, et al. Multicenter experience in revascularization of very elderly patients. Am Heart J. 2004; 148: 486-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Multicenter experience in revascularization of very elderly patients</article-title>
          <source>Am Heart J.</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>486</fpage>
          <lpage>92</lpage>
          <volume>148</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Peterson</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Malenka</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Hannan</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>O'Conner</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>McCallister</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Igl&#233;zias JCR, Louren&#231;&#227;o Jr A, Dallan LAO, Puig LB, Oliveira SA. Revasculariza&#231;&#227;o do mioc&#225;rdio no paciente idoso - com ou sem circula&#231;&#227;o extracorp&#243;rea? Rev Bras Cir Cardiovasc. 2003; 18 (4): 321-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Revasculariza&#231;&#227;o do mioc&#225;rdio no paciente idoso - com ou sem circula&#231;&#227;o extracorp&#243;rea</article-title>
          <source>Rev Bras Cir Cardiovasc.</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>321</fpage>
          <lpage>5</lpage>
          <issue>4</issue>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Igl&#233;zias</surname>
              <given-names>JCR</given-names>
            </name>
            <name>
              <surname>Louren&#231;&#227;o</surname>
              <given-names>Jr A</given-names>
            </name>
            <name>
              <surname>Dallan</surname>
              <given-names>LAO</given-names>
            </name>
            <name>
              <surname>Puig</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Igl&#233;zias JCR, Louren&#231;&#227;o Jr A, Dallan LAO, Puig LB, Stolf NAG. Aumento absoluto de risco pela associa&#231;&#227;o de procedimentos &#224; revasculariza&#231;&#227;o no idoso [resumo]. Arq Bras Cardiol. 2007; 89 (supl 1): 25.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Aumento absoluto de risco pela associa&#231;&#227;o de procedimentos &#224; revasculariza&#231;&#227;o no idoso [resumo]</article-title>
          <source>Arq Bras Cardiol.</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>25</fpage>
          <issue>supl 1</issue>
          <volume>89</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Igl&#233;zias</surname>
              <given-names>JCR</given-names>
            </name>
            <name>
              <surname>Louren&#231;&#227;o</surname>
              <given-names>Jr A</given-names>
            </name>
            <name>
              <surname>Dallan</surname>
              <given-names>LAO</given-names>
            </name>
            <name>
              <surname>Puig</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Stolf</surname>
              <given-names>NAG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. L&#243;pez-Rodr&#237;guez FJ, Gonz&#225;lez-Santos JM, Dalmau MJ, Bueno M. Cirurg&#237;a card&#237;aca en el anciano: comparaci&#243;n de resultados a medio plazo entre octogenarios y ancianos de 75 a 79 a&#241;os. Rev Esp Cardiol. 2008; 61 (6): 579-88.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cirurg&#237;a card&#237;aca en el anciano: comparaci&#243;n de resultados a medio plazo entre octogenarios y ancianos de 75 a 79 a&#241;os</article-title>
          <source>Rev Esp Cardiol.</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>579</fpage>
          <lpage>88</lpage>
          <issue>6</issue>
          <volume>61</volume>
          <person-group person-group-type="author">
            <name>
              <surname>L&#243;pez-Rodr&#237;guez</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Gonz&#225;lez-Santos</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Dalmau</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Bueno</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Peterson ED, Cowper PA, Jollis JG, Bebchuk JD, DeLong ER, Muhlbaier LH, et al. Outcomes of coronary artery bypass graft surgery in 24461 patients aged 80 years or older. Circulation. 1995; 92 (Suppl II): II-85-II91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Outcomes of coronary artery bypass graft surgery in 24461 patients aged 80 years or older</article-title>
          <source>Circulation.</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>II</fpage>
          <issue>Suppl II</issue>
          <volume>92</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Peterson</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Cowper</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Jollis</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Bebchuk</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>DeLong</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Muhlbaier</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Almeida RMS, Lima Jr JD, Martins JF, Loures DRR. Revasculariza&#231;&#227;o do mioc&#225;rdio em pacientes ap&#243;s a oitava d&#233;cada de vida. Rev Bras Cir Cardiovasc. 2002; 17 (2): 8-14.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Revasculariza&#231;&#227;o do mioc&#225;rdio em pacientes ap&#243;s a oitava d&#233;cada de vida</article-title>
          <source>Rev Bras Cir Cardiovasc.</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>8</fpage>
          <lpage>14</lpage>
          <issue>2</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Almeida</surname>
              <given-names>RMS</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>Jr JD</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Loures</surname>
              <given-names>DRR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Nagpal AD, Bhatnagar G, Cutrara CA, Ahmed SM, McKenzie N, Quantz M, et al. Early outcomes of coronary artery bypass with and without cardiopulmonary bypass in octogenarians. Can J Cardiol. 2006; 22 (10): 849-53.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Early outcomes of coronary artery bypass with and without cardiopulmonary bypass in octogenarians</article-title>
          <source>Can J Cardiol.</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>849</fpage>
          <lpage>53</lpage>
          <issue>10</issue>
          <volume>22</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nagpal</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Bhatnagar</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cutrara</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>McKenzie</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Quantz</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Li Y, Zheng Z, Hu S. Early and long-term outcomes in the elderly: comparison between off-pump and on-pump techniques in 1191 patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2008; 136: 657-64.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Early and long-term outcomes in the elderly: comparison between off-pump and on-pump techniques in 1191 patients undergoing coronary artery bypass grafting</article-title>
          <source>J Thorac Cardiovasc Surg.</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>657</fpage>
          <lpage>64</lpage>
          <volume>136</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Jones RH. The year in cardiovascular surgery. J Am Coll Cardiol. 2008; 51 (17): 1707-18.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The year in cardiovascular surgery</article-title>
          <source>J Am Coll Cardiol.</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1707</fpage>
          <lpage>18</lpage>
          <issue>17</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Tyszka AL, Fucuda LS. O uso da art&#233;ria tor&#225;cica interna no idoso: indica&#231;&#245;es e resultados imediatos. Rev Bras Cir Cardiovasc. 2001; 16 (4): 269-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>O uso da art&#233;ria tor&#225;cica interna no idoso: indica&#231;&#245;es e resultados imediatos</article-title>
          <source>Rev Bras Cir Cardiovasc.</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>269</fpage>
          <lpage>74</lpage>
          <issue>4</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tyszka</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Fucuda</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Instituto Brasileiro de Geografia e Estat&#237;stica (IBGE). Expectativa de vida da popula&#231;&#227;o brasileira. [Acesso em 2008 dez 10]. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://www.ibge.gov.br">http://www.ibge.gov.br</ext-link> </mixed-citation>
        <element-citation publication-type="book">
          <source>Expectativa de vida da popula&#231;&#227;o brasileira</source>
          <date>
            <year>2008</year>
            <month>12</month>
          </date>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Stoica SC, Cafferty F, Kitcat J, Baskett RJF, Goddard M, Sharples LD, et al. Octogenarians undergoing cardiac surgery outlive their peers: a case for early referral. Heart. 2006; 92: 503-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Octogenarians undergoing cardiac surgery outlive their peers: a case for early referral</article-title>
          <source>Heart.</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>503</fpage>
          <lpage>6</lpage>
          <volume>92</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stoica</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Cafferty</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kitcat</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Baskett</surname>
              <given-names>RJF</given-names>
            </name>
            <name>
              <surname>Goddard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sharples</surname>
              <given-names>LD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Sociedade Brasileira de Cardiologia. Diretrizes da cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica. Arq Bras Cardiol. 2004; 82 (supl 5): 1-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diretrizes da cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica</article-title>
          <source>Arq Bras Cardiol.</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1</fpage>
          <lpage>20</lpage>
          <issue>supl 5</issue>
          <volume>82</volume>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Morbimortalidad en octogenarios sometidos a cirug&#237;a de revascularizaci&#243;n mioc&#225;rdica</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: El progresivo aumento de la longevidad de la poblaci&#243;n ha llevado cada vez m&#225;s pacientes octogenarios a necesitar cirug&#237;a de revascularizaci&#243;n mioc&#225;rdica (CRM), siendo necesario conocer los riesgos y beneficios de ese procedimiento en esa franja etaria. OBJETIVO: Describir la morbimortalidad hospitalaria de pacientes con edad igual o superior a 80 a&#241;os sometidos a CRM e identificar variables que se constituyen en sus predictores. M&#201;TODOS: Fueron estudiados 140 casos consecutivos entre enero de 2002 y diciembre de 2007. Los pacientes pose&#237;an en media 82,5 &#177; 2,2 a&#241;os (80-89), y 55,7% eran de sexo masculino. En la muestra, 72,9% ten&#237;an hipertensi&#243;n arterial, 26,4% diabetes, 65,7% lesi&#243;n grave en tres o m&#225;s vasos y 28,6% en tronco de la coronaria izquierda. Cirug&#237;a asociada estuvo presente en 35,7% de los pacientes, siendo la valvar a&#243;rtica en 26,4% y la mitral en 5,6%. RESULTADOS: La mortalidad fue de 14,3% (CRM aislada 10,0% x 22,0% asociada; p = 0,091) y la morbilidad de 37,9% (CRM aislada 34,4% x 44,0% asociada; p = 0,35). Complicaciones m&#225;s frecuentes: bajo d&#233;bito card&#237;aco (27,9%), disfunci&#243;n renal (10,0%) y asistencia ventilatoria prolongada (9,6%). En el an&#225;lisis bivariado, los mayores predictores de mortalidad fueron sepsis (RR 10,2 IC 95%: 6,10-17,7), CRM previa (RR 8,06 IC 95%: 5,16-12,6), bajo d&#233;bito card&#237;aco post-operatorio (RR 7,77 IC 95%: 3,03-19,9) y disfunci&#243;n renal post-operatoria (RR 7,36 IC 95%: 3,71-14,6). En cuanto a la morbilidad, fueron predictores, tiempo de circulaci&#243;n extracorp&#243;rea &gt;120 min. (RR: 2,34 IC 95%: 1,62-3,38) e de isquemia &gt; 90 min. (RR: 2,29 IC 95%: 1,56-3,37). CONCLUSI&#211;N: La CRM en octogenarios est&#225; relacionada a una morbimortalidad mayor que en los pacientes m&#225;s j&#243;venes, lo que, mientas tanto, no impide la intervenci&#243;n si hubiere indicaci&#243;n por la condici&#243;n cl&#237;nica.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Revascularizaci&#243;n mioc&#225;rdica</kwd>
        <kwd>mortalidad</kwd>
        <kwd>morbilidade</kwd>
        <kwd>a&#241;oso de 80 a&#241;os o m&#225;s</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <bold>Morbimortalidad en octogenarios sometidos a cirug&#237;a de revascularizaci&#243;n mioc&#225;rdica</bold>
      </p>
      <p>
        <bold>Fernando Pivatto J&#250;nior<sup>I,II</sup>; Renato A. K. Kalil<sup>I,II</sup>; Altamiro R. Costa<sup>I</sup>; Edemar M. C. Pereira<sup>I,II</sup>; Eduardo Z. Santos<sup>I,II</sup>; Felipe H. Valle<sup>I,II</sup>; Luciano P. Bender<sup>I,II</sup>; Marcelo Trombka<sup>I,II</sup>; Tha&#237;s B. Modkovski<sup>I,II</sup>; Ivo A. Nesralla<sup>I</sup></bold>
      </p>
      <p><sup>I</sup>Instituto de Cardiologia do Rio Grande do Sul/FUC - IC-FUC</p>
      <p><sup>II</sup>Universidade Federal de Ci&#234;ncias da Sa&#250;de de Porto Alegre - UFCSPA, Porto Alegre, RS - Brasil</p>
      <p>
        <xref ref-type="corresp" rid="end-body2">Correspondencia</xref>
      </p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> El progresivo aumento de la longevidad de la poblaci&#243;n ha llevado cada vez m&#225;s pacientes octogenarios a necesitar cirug&#237;a de revascularizaci&#243;n mioc&#225;rdica (CRM), siendo necesario conocer los riesgos y beneficios de ese procedimiento en esa franja etaria.</p>
      <p><bold>OBJETIVO:</bold> Describir la morbimortalidad hospitalaria de pacientes con edad igual o superior a 80 a&#241;os sometidos a CRM e identificar variables que se constituyen en sus predictores.</p>
      <p><bold>M&#201;TODOS:</bold> Fueron estudiados 140 casos consecutivos entre enero de 2002 y diciembre de 2007. Los pacientes pose&#237;an en media 82,5 &#177; 2,2 a&#241;os (80-89), y 55,7% eran de sexo masculino. En la muestra, 72,9% ten&#237;an hipertensi&#243;n arterial, 26,4% diabetes, 65,7% lesi&#243;n grave en tres o m&#225;s vasos y 28,6% en tronco de la coronaria izquierda. Cirug&#237;a asociada estuvo presente en 35,7% de los pacientes, siendo la valvar a&#243;rtica en 26,4% y la mitral en 5,6%.</p>
      <p><bold>RESULTADOS:</bold> La mortalidad fue de 14,3% (CRM aislada 10,0% x 22,0% asociada; p = 0,091) y la morbilidad de 37,9% (CRM aislada 34,4% x 44,0% asociada; p = 0,35). Complicaciones m&#225;s frecuentes: bajo d&#233;bito card&#237;aco (27,9%), disfunci&#243;n renal (10,0%) y asistencia ventilatoria prolongada (9,6%). En el an&#225;lisis bivariado, los mayores predictores de mortalidad fueron sepsis (RR 10,2 IC 95%: 6,10-17,7), CRM previa (RR 8,06 IC 95%: 5,16-12,6), bajo d&#233;bito card&#237;aco post-operatorio (RR 7,77 IC 95%: 3,03-19,9) y disfunci&#243;n renal post-operatoria (RR 7,36 IC 95%: 3,71-14,6). En cuanto a la morbilidad, fueron predictores, tiempo de circulaci&#243;n extracorp&#243;rea <underline>&gt;</underline>120 min. (RR: 2,34 IC 95%: 1,62-3,38) e de isquemia <underline>&gt;</underline> 90 min. (RR: 2,29 IC 95%: 1,56-3,37).</p>
      <p><bold>CONCLUSI&#211;N:</bold> La CRM en octogenarios est&#225; relacionada a una morbimortalidad mayor que en los pacientes m&#225;s j&#243;venes, lo que, mientas tanto, no impide la intervenci&#243;n si hubiere indicaci&#243;n por la condici&#243;n cl&#237;nica.</p>
      <p><bold>Palabras clave:</bold> Revascularizaci&#243;n mioc&#225;rdica, mortalidad, morbilidade, a&#241;oso de 80 a&#241;os o m&#225;s.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>En los &#250;ltimos a&#241;os, la poblaci&#243;n de pacientes a&#241;osos ha aumentado de manera considerable, tanto en los pa&#237;ses desarrollados como tambi&#233;n en los pa&#237;ses considerados en desarrollo<sup>1</sup>. Los datos demogr&#225;ficos brasile&#241;os se&#241;alan un evidente aumento de esa poblaci&#243;n, con estimativas que colocan al Brasil como la sexta poblaci&#243;n de a&#241;osos del mundo en 2025<sup> 2</sup>.</p>
      <p>La enfermedad cardiovascular es extremadamente prevalente en esa franja etaria, con aproximadamente 40% de los octogenarios presentando enfermedad cardiovascular sintom&#225;tica<sup>3</sup>. Diversos modelos de estudio epidemiol&#243;gico prev&#233;n que, con las actuales tasas de crecimiento de la poblaci&#243;n a&#241;osa, habr&#225; no s&#243;lo un aumento en la incidencia de la enfermedad arterial coronaria, sino tambi&#233;n en la mortalidad total y en el costo econ&#243;mico, debiendo haber, probablemente, en las pr&#243;ximas d&#233;cadas, un aumento progresivo del n&#250;mero de pacientes a&#241;osos que se presentan a los servicios de cirug&#237;a card&#237;aca<sup>4</sup>.</p>
      <p>Actualmente, es habitual la indicaci&#243;n de cirug&#237;a de revascularizaci&#243;n mioc&#225;rdica (CRM) en septuagenarios, lo que se vuelve cada vez m&#225;s com&#250;n en octogenarios y no es raro en nonagenario<sup>5</sup>. La edad avanzada ha sido ampliamente mostrada la literatura como una variable correlacionada con la mortalidad operatoria: por diversas razones, puede ser considerada como factor de alto riesgo en procedimientos quir&#250;rgicos de gran porte, especialmente en cirug&#237;as card&#237;acas<sup>4</sup>.</p>
      <p>La mortalidad operatoria en pacientes con edad igual o superior a 70 a&#241;os vari&#243; de5 a 20% en los &#250;ltimos 20 a&#241;os para CRM aislada, siendo en media de 8,9%. La directriz de la ACC/AHA refiere mortalidad de 5,28% encima de los 75 a&#241;os y de 8,38% por encima de los 80 a&#241;os<sup>6</sup>.</p>
      <p>Este trabajo tuvo como objetivo principal describir la morbimortalidad hospitalaria de pacientes octogenarios sometidos a CRM y, secundariamente, identificar variables pre, trans y post operatorias predictoras de morbilidad y/o mortalidad.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>Este estudio retrospectivo abarc&#243; todos los pacientes consecutivos con edad igual o superior a 80 a&#241;os sometidos a CRM en el per&#237;odo de enero de 2002 a diciembre de 2007 en el Instituto de Cardiolog&#237;a de R&#237;o Grande do Sul. Las variables incluidas en este estudio est&#225;n descriptas en la <xref ref-type="table" rid="tab1-body2">Tabla 1</xref>.</p>
      <table-wrap id="tab1-body2">
        <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt01-es.jpg"/></table-wrap>
      <p>La disfunci&#243;n renal, tanto pre como post operatoria, fue definida por el nivel s&#233;rico de creatinina superior a 2 mg/ml. La clasificaci&#243;n de insuficiencia card&#237;aca sigui&#243; los criterios establecidos por la <italic>New York Heart Association</italic>. (NYHA) Fue considerada lesi&#243;n coronaria grave la superior al 70% en las arterias coronarias o a 50% en el tronco de la coronaria izquierda (TCE). La fracci&#243;n de eyecci&#243;n fue considerada baja cuando era menor que 50% y normal si era superior a ese valor. Bajo d&#233;bito cardiaco fue considerado toda inestabilidad hemodin&#225;mica con necesidad de drogas m&#225;s activas o de bal&#243;n intra a&#243;rtico. Alteraciones neurol&#243;gicas localizadas o alteraciones del nivel de conciencia por un per&#237;odo superior a 24 horas fueron definidas como accidente vascular cerebral. Mortalidad hospitalaria fue definida como cualquier &#243;bito durante la internaci&#243;n del paciente, independientemente de su duraci&#243;n. La ocurrencia de cualquiera o de uno de estos eventos en el postoperatorio fue definida como morbilidad operatoria: bajo d&#233;bito cardiaco, uso del bal&#243;n intra a&#243;rtico, sepsis, infecci&#243;n de la herida operatoria o del miembro inferior, disfunci&#243;n renal, accidente vascular cerebral, reintervenci&#243;n por sangrado y tiempo de asistencia ventilatoria prolongada, superior a 48 horas.</p>
      <p>En vista de la estructura retrospectiva de este estudio, hubo p&#233;rdida, ya esperada, de algunos datos ausentes en las historias cl&#237;nicas. Esto ocurri&#243;, con m&#225;s frecuencia en las variables clase funcional NYHA, fracci&#243;n de eyecci&#243;n, tiempo de circulaci&#243;n extracorp&#243;rea, de isquemia y de asistencia ventilatoria .</p>
      <p>Los datos fueron recolectados directamente a partir de las historias cl&#237;nicas, siendo incluidos y analizados en el software SPSS 15.0. El an&#225;lisis descriptivo para las variables cualitativas fue realizado a partir de la distribuci&#243;n de frecuencia absoluta y relativa, y para las cuantitativas a trav&#233;s de la media y del desv&#237;o est&#225;ndar. A fin de evaluar estad&#237;sticamente la asociaci&#243;n entre dos variables cualitativas fue utilizado el test del qui cuadrado o exacto de Fisher cuando era indicado. Para comparar la media de las variables cuantitativas en relaci&#243;n a la mortalidad fue utilizado el test <italic>t</italic> de <italic>Student</italic>. Para evaluar la relaci&#243;n entre riesgo de mortalidad y las variables fue utilizada la regresi&#243;n de Poisson. El nivel de significancia adoptado en todos los tests fue de 5%. En funci&#243;n de la baja mortalidad encontrada y de la presencia de diversas variables significativas en el an&#225;lisis de regresi&#243;n bruta de Poisson, no fue realizado el an&#225;lisis multivariado</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>La muestra obtenida fue de 140 pacientes, en un universo de 4.203 revascularizaciones quir&#250;rgicas (3,3%), siendo 78 (55,5%) masculinos. La edad de los pacientes vari&#243; de 80 a 89 a&#241;os, con una media de 82,5 &#177; 2,2. Las caracter&#237;sticas de la poblaci&#243;n est&#225;n descriptas en la <xref ref-type="table" rid="tab2-body2">Tabla 2</xref>.</p>
      <table-wrap id="tab2-body2">
        <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt02-es.jpg"/></table-wrap>
      <p>En relaci&#243;n a los datos quir&#250;rgicos, todos los procedimientos fueron realizados con circulaci&#243;n extracorp&#243;rea. La arteria mamaria interna fue utilizada en 24,3% de los pacientes, la media de tiempo de la circulaci&#243;n extracorp&#243;rea fue 85,4 &#177; 28,8 minutos y el de isquemia mioc&#225;rdica 58,0 &#177; 22,3 minutos. Cirug&#237;a asociada fue realizada en 50 (35,7%) pacientes. Los procedimientos asociados est&#225;n listados en la <xref ref-type="table" rid="tab3-body2">Tabla 3</xref>.</p>
      <table-wrap id="tab3-body2">
        <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt03-es.jpg"/></table-wrap>
      <p>Cincuenta y tres pacientes (37,9%) presentaron al menos una complicaci&#243;n en el per&#237;odo post-operatorio. En los pacientes con revascularizaci&#243;n aislada, la tasa de complicaciones fue de 34,4%, no habiendo diferencia significativa al comparar con el grupo sometido a otro procedimiento asociado (44,0%; p = 0,35).</p>
      <p>La <xref ref-type="table" rid="tab4-body2">Tabla 4</xref> muestra la prevalencia de las complicaciones post-operatorias analizadas, siendo posible observar que el bajo d&#233;bito card&#237;aco fue la intercurrencia m&#225;s com&#250;n (27,9%).</p>
      <table-wrap id="tab4-body2">
        <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt04-es.jpg"/></table-wrap>
      <p>La mortalidad hospitalaria fue de 14,3% (20 pacientes), siendo de 10% en los pacientes sometidos a revascularizaci&#243;n aislada y de 22% en los sometidos a otro procedimiento asociado: esa diferencia no fue estad&#237;sticamente significativa (p = 0,091). Choque cardiog&#233;nico fue la principal causa de &#243;bito encontrada, siendo responsable por el fallecimiento de 11 (55,0%) pacientes.</p>
      <p>Los factores de riesgo para mortalidad hospitalaria est&#225;n descriptos en la <xref ref-type="table" rid="es_a07tab05-body2">Tabla 5</xref>. Los dem&#225;s factores analizados no se mostraron significativos en an&#225;lisis bivariado.</p>
      <p content-type="asset">
        <table-wrap id="es_a07tab05-body2">
          <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt05-es.jpg"/></table-wrap>
      </p>
      <p>En relaci&#243;n a los predictores de morbilidad, s&#243;lo los tiempos de circulaci&#243;n extracorp&#243;rea y de isquemia prolongados se mostraron estad&#237;sticamente significativos (<xref ref-type="table" rid="es_a07tab06-body2">Tabla 6</xref>).</p>
      <p content-type="asset">
        <table-wrap id="es_a07tab06-body2">
          <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt06-es.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>Con creciente frecuencia ocurre la necesidad de decisi&#243;n sobre el mejor tratamiento de la enfermedad arterial coronaria en pacientes de m&#225;s de 80 a&#241;os. El envejecimiento promueve el aumento de comorbilidades, adem&#225;s del aumento de la prevalencia de enfermedad arterial coronaria y de sus consecuencias en los m&#225;s a&#241;osos<sup>7</sup>.</p>
      <p>La indicaci&#243;n quir&#250;rgica en los pacientes octogenarios busca, principalmente, el alivio de los s&#237;ntomas y una mejora la calidad de vida, una vez que el resultado a largo plazo est&#225; limitado por la expectativa de vida en esta franja etaria y todav&#237;a puede ser afectado por el surgimiento, en otros &#243;rganos de enfermedades relativas a la propia edad<sup>1</sup> . En los &#250;ltimos a&#241;os la CRM ha sido ejecutada en pacientes cada vez m&#225;s a&#241;osos, con envolvimiento multivascular coronario, disfunci&#243;n ventricular izquierda y otras afecciones cr&#243;nico degenerativas asociadas. Las caracter&#237;sticas de la poblaci&#243;n de estudios comprueban tales peculiaridades, en la medida en que el 65,7% de los pacientes pose&#237;an lesi&#243;n grave y arterial, 26,4% diabetes y 72, 9% hipertensi&#243;n y diabetes , frecuencias semejantes a los datos de la literatura<sup>8-10</sup> . Tal hecho representa una caracter&#237;stica importante de esa poblaci&#243;n, la cual contribuye al aumento de su riesgo quir&#250;rgico.</p>
      <p>La combinaci&#243;n de enfermedad coronaria m&#225;s avanzada y de peores comorbilidades ocasiona un aumento de complicaciones fatales y no fatales, con mayores tasas de infarto de miocardio intra o post operatorio, bajo d&#233;bito cardiaco, accidente vascular cerebral, complicaciones gastrointestinales infecci&#243;n de la herida operatoria, insuficiencia renal y uso de bal&#243;n intra a&#243;rtico<sup>6</sup>. En el presente estudio, la complicaci&#243;n m&#225;s frecuente fue el bajo d&#233;bito cardiaco (27,9%), como ocurrieron tambi&#233;n otras series<sup>4-11</sup>.</p>
      <p>La mortalidad hospitalaria de 14,3% de esta serie de casos encuentra concordancia con la literatura. En el mismo periodo de este levantamiento, fueron realizados en el Instituto de Cardiolog&#237;a de 3.530 cirug&#237;as de revascularizaci&#243;n aislada, con mortalidad hospitalaria global de 3,7%, y 673 revascularizaciones con cirug&#237;as asociadas, cuya mortalidad fue de 10,3%. La distinci&#243;n de las tasas de mortalidad del procedimiento aislado (10%) y del asociado a otro procedimiento es relevante, ya que es sabido que la realizaci&#243;n de la cirug&#237;a asociada incrementa el riesgo de mortalidad. Iglesias y cols<sup>12</sup> demostraron un aumento de 25% en la mortalidad hospitalaria, con diferencia estad&#237;sticamente significativa(p=0,002) para el grupo que realiz&#243; cirug&#237;a aislada, diferentemente lo que ocurri&#243; en la presente investigaci&#243;n</p>
      <p>L&#243;pez-Rodr&#237;guez y cols<sup>13</sup> en an&#225;lisis reciente de 140 octogenarios sometidos a cirug&#237;a cardiaca, encontraron una mortalidad de 8,3% en la cirug&#237;a aislada y de 21,4% en la asociada, siendo que en ese estudio la circulaci&#243;n extracorp&#243;rea no fue utilizada en 25% de los pacientes. Peterson y cols<sup>14</sup> realizaron el mayor estudio con pacientes octogenarios hasta el presente momento, incluyendo 24.461 pacientes sometidos a cirug&#237;a aislada, describiendo una mortalidad hospitalaria de 11,5%</p>
      <p>Varios trabajos han relatado los resultados de la CRM en a&#241;osos, por tratarse de un grupo diferente de pacientes principalmente en relaci&#243;n a las asociaciones con otras enfermedades en el preoperatorio y a las complicaciones que pueda aparecer despu&#233;s del procedimiento<sup>15</sup>. Mientras tanto, hasta el presente momento, hay pocos estudios en el escenario nacional que abordan a los pacientes octogenarios, siendo esa la contribuci&#243;n de este art&#237;culo.</p>
      <p>Iglesias y cols<sup>4</sup> analizaron 361 pacientes con edad igual o superior a 70 a&#241;os (media 73,9 m&#225;s -3,3 pasos) sometidos a CRM aislada, describiendo una mortalidad de 9,1% en 30 d&#237;as. Ese mismo grupo analiz&#243; en otro estudio 100 pacientes sometidos a CRM aislada con edad tambi&#233;n igual o mayor a 70 a&#241;os, haciendo mitad operados con circulaci&#243;n extracorp&#243;rea (CEC) y la otra mitad sin esa t&#233;cnica, teniendo ambos grupos media de edad superior a 75 a&#241;os. La sobrevida en 30 d&#237;as fue de 92% para los operados con CEC y de 96% para los operados sin CEC no habiendo diferencia estad&#237;sticamente significativa.</p>
      <p>En relaci&#243;n a los procedimientos quir&#250;rgicos de este estudio, como ya fue descripto, todos fueron realizados utilizando CEC. Los beneficios de la realizaci&#243;n de cirug&#237;a cardiaca sin CEC <italic>(off pump)</italic> en a&#241;osos ha sido motivo de discusi&#243;n hace alg&#250;n tiempo. En art&#237;culo reciente, cuyo objetivo fue comparar los resultados de la CRM sin CDC en octogenarios con la cirug&#237;a convencional, no fue observada diferencia estad&#237;sticamente significativa en la mortalidad entre esos grupos (convencional 6,7% <italic>vs</italic> 3,1%; p=0,22)<sup> 22</sup> Li y cols<sup>17</sup>, en an&#225;lisis de 1191 pacientes con edad superior a 65 a&#241;os, observaron que la CRM sin CDC estuvo asociada a desenlaces precoces m&#225;s favorables, los cuales, mientras tanto, no se mantuvieron en el seguimiento, siendo la cirug&#237;a tradicional relacionada a mejores resultados a medio y largo plazo. Esta observaci&#243;n fue ratificada en art&#237;culo de revisi&#243;n reciente, en el cual fue observado que las evidencias actuales sugieren que CRM sin CEC puede ofrecer una menor morbilidad perioperatoria, pero al costo de una menor efectividad a largo plazo.<sup>18</sup></p>
      <p>La arteria a&#243;rtica interna (ATI) es el mejor injerto para revascularizaci&#243;n mioc&#225;rdica en t&#233;rminos de patencia a largo plazo, libre recurrencia de angina y de eventos card&#237;acos tard&#237;os. Debido a que el aparente beneficio de la utilizaci&#243;n de la ATI ha sido m&#225;s enfatizado en cuanto a los resultados tard&#237;os de patencia y sobrevida, muchos cirujanos evitaban su uso en pacientes a&#241;osos, asumiendo no estar agregando sustancial beneficio a esa poblaci&#243;n<sup>19</sup>. En el Brasil la expectativa de vida actual es de 72,4 a&#241;os; sin embargo los individuos que alcanzan la edad de 80 a&#241;os tienen en media m&#225;s de 9,4 a&#241;os de sobrevida<sup>20</sup>. Por lo tanto, m&#225;s importante que la expectativa de vida global de la poblaci&#243;n general es la expectativa de quien alcanza los 80 a&#241;os. En relaci&#243;n a los pacientes octogenarios sometidos a CRM aislada, los estudios demostraron una sobrevida semejante<sup>14</sup> o a&#250;n superior<sup>21</sup> a la de la poblaci&#243;n general. Por lo tanto la no utilizaci&#243;n de la ATI en el a&#241;oso, debido a la presunta p&#233;rdida de importancia de su patencia tard&#237;a, no puede ser vista como correcta.</p>
      <p>La baja tasa de utilizaci&#243;n de la ATI en este estudio (24,3%) se justifica por su car&#225;cter retrospectivo, en el cual se verific&#243; la realidad de un hospital por un largo per&#237;odo de tiempo, en donde la opini&#243;n del uso de ese injerto en la franja etaria en cuesti&#243;n se modific&#243;, siendo la preferencia actual de la mayor&#237;a de los cirujanos, el implante de mamarias aun en octogenarios.</p>
      <p>Los predictores de mortalidad hospitalaria mostrados en <xref ref-type="table" rid="tab4-body2">Tabla 4</xref> son semejantes a los encontrados en otros estudios en a&#241;osos. Los predictores m&#225;s significativos fueron sepsis, CRM previa, bajo cr&#233;dito card&#237;aco post operatorio y disfunci&#243;n renal, tanto pre como post operatoria. Es importante destacar nuevamente la limitaci&#243;n de este estudio por la imposibilidad de, en virtud de la reducida muestra y del gran n&#250;mero de variables proyectadas significativas en an&#225;lisis bivariado, realizar un an&#225;lisis multivariado, en el cual podr&#237;a ser obtenidas indicaciones de predictores independientes de mortalidad hospitalaria.</p>
      <p>En an&#225;lisis de 589 pacientes con edad superior a 75 a&#241;os sometidos a cirug&#237;a cardiaca L&#243;pez-Rodr&#237;guez y cols<sup>13</sup> verificaron el tiempo de circulaci&#243;n extracorp&#243;rea prolongado, superior a 120 minutos, como predictor independiente de morbilidad post operatoria. En el presente estudio, esa variable se mostr&#243; predictora en an&#225;lisis bivariado, as&#237; como el tiempo de isquemia prolongado.</p>
      <p>Seg&#250;n las directrices de la Sociedad Brasile&#241;a de Cardiolog&#237;a<sup>22</sup>, la edad no debe ser contraindicaci&#243;n para la realizaci&#243;n de la cirug&#237;a, siendo importante evaluar la era real con la aparente, el estado general y las capacidades f&#237;sicas e intelectuales del paciente. De acuerdo con las directrices de la ACC/AHA<sup>6</sup> el paciente y el m&#233;dico deben explorar juntos los potenciales beneficios de mejora de la calidad de vida, observando los riesgos del procedimiento en comparaci&#243;n con una terapia alternativa, tambi&#233;n tomando en cuenta la capacidad funcional basal y la preferencia del paciente. La edad aisladamente no debe ser una contraindicaci&#243;n para CRM, si consideramos que los beneficios superan el riesgo del procedimiento a largo plazo.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>La CRM en octogenarios est&#225; relacionada a una morbimortalidad mayor que en pacientes m&#225;s j&#243;venes, lo que, mientras tanto, no impide la intervenci&#243;n si hubiere indicaci&#243;n por su condici&#243;n cl&#237;nica. Las complicaciones m&#225;s frecuentes fueron bajo d&#233;bito cardiaco, disfunci&#243;n renal, y asistencia ventilatoria prolongada. Los mayores predictores de mortalidad fueron sepsis, CRM previa, bajo d&#233;bito cardiaco post operatorio y disfunci&#243;n renal post operatoria. En cuanto a la morbilidad, fueron predictores, tiempo de circulaci&#243;n extracorp&#243;rea 120 minutos y de isquemia 90 minutos. As&#237; la indicaci&#243;n de cirug&#237;a debe ser criteriosamente evaluada e individualizada, tomando en consideraci&#243;n la edad y estado general del paciente, su expectativa de vida, sus probabilidades de retorno a la vida social, la localizaci&#243;n y gravedad de las lesiones coronarias, la extensi&#243;n del miocardio bajo isquemia, la intensidad de los s&#237;ntomas, la presencia de comorbilidades, la experiencia del equipo quir&#250;rgico y los resultados comparativos con las otras formas de tratamiento, sea farmacol&#243;gico o a trav&#233;s de angioplastia percut&#225;nea .</p>
      <p>
        <bold>Agradecimientos</bold>
      </p>
      <p>Agradecimientos a los doctores Guaracy Fernandes Teixeira Filho, Paulo Roberto Prates y Jo&#227;o Ricardo Michielin Sant'Anna, miembros del Equipo de Cirug&#237;a Cardiovascular del IC-FUC.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>No hay vinculaci&#243;n de este estudio a programas de postgrado.</p>
      <p>
        <bold>Referencias</bold>
      </p>
      <p>1. Lima R, Diniz R, C&#233;sio A, Vasconcelos F, Gesteira M, Menezes A, et al. Revasculariza&#231;&#227;o mioc&#225;rdica em pacientes octogen&#225;rios: estudo retrospectivo e comparativo entre pacientes operados com e sem circula&#231;&#227;o extracorp&#243;rea. Rev Bras Cir Cardiovasc. 2005; 20 (1): 8-13.</p>
      <p>2. Whitaker JF, Passos PHC, Ramalho GM, Muniz AJ, Pimentel RC, Loures JBL, et al. Utiliza&#231;&#227;o da art&#233;ria radial como segundo enxerto arterial em pacientes acima de 70 anos. Rev Bras Cir Cardiovasc. 2005; 20 (1): 58-62.</p>
      <p>3. Loures DRR, Carvalho RG, Mulinari L, Silva Jr AZ, Schmidlin CA, Brommelstr&#246;et M, et al. Cirurgia card&#237;aca no idoso. Rev Bras Cir Cardiovasc. 2000; 15 (1): 1-5.</p>
      <p>4. Igl&#233;zias JCR, Oliveira Jr. JL, Dallan LAO, Louren&#231;&#227;o Jr A, Stolf NAG. Preditores de mortalidade hospitalar no paciente idoso portador de doen&#231;a arterial coron&#225;ria. Rev Bras Cir Cardiovasc. 2001; 16 (2): 94-104.</p>
      <p>5. Kalil RAK. Consensos e controv&#233;rsias na doen&#231;a arterial coronariana cr&#244;nica: quando indicar a cirurgia? Revista da Sociedade de Cardiologia do Rio Grande do Sul, 2008; 13: 1-3.</p>
      <p>6. Eagle KA, Guyton RA, Davidoff R, Eduwards FH, Ewy GA, Gardner TJ, et al. ACC / AHA 2004 guideline update for coronary artery bypass graft surgery: a report ACC/AHA Task Force on Practice Guideline. Circulation. 2004; 110 (14): e340-437.</p>
      <p>7. Wajngarten M, Oliveira SA. Doen&#231;a coronariana no grande idoso: conduta conservadora ou agressiva? Arq Bras Cardiol. 2003; 81(3): 219-20.</p>
      <p>8. Nagano N, Kohmoto T, Hirose H, Amano A, Yoshida S, Takahashi A. Coronary artery bypass grafting in the elderly. Chest. 2000; 117: 1262-70. </p>
      <p>9. Bardakci H, Cheema FH, Topkara VK, Dang NC, Martens TP, Mercando ML, et al. Discharge to home rates are significantly lower for octogenarians undergoing coronary artery bypass graft surgery. Ann Thorac Surg. 2007; 83: 483-9.</p>
      <p>10. Peterson ED, Alexander KP, Malenka DJ, Hannan EL, O'Conner GT, McCallister BD, et al. Multicenter experience in revascularization of very elderly patients. Am Heart J. 2004; 148: 486-92.</p>
      <p>11. Igl&#233;zias JCR, Louren&#231;&#227;o Jr A, Dallan LAO, Puig LB, Oliveira SA. Revasculariza&#231;&#227;o do mioc&#225;rdio no paciente idoso - com ou sem circula&#231;&#227;o extracorp&#243;rea? Rev Bras Cir Cardiovasc. 2003; 18 (4): 321-5.</p>
      <p>12. Igl&#233;zias JCR, Louren&#231;&#227;o Jr A, Dallan LAO, Puig LB, Stolf NAG. Aumento absoluto de risco pela associa&#231;&#227;o de procedimentos &#224; revasculariza&#231;&#227;o no idoso [resumo]. Arq Bras Cardiol. 2007; 89 (supl 1): 25.</p>
      <p>13. L&#243;pez-Rodr&#237;guez FJ, Gonz&#225;lez-Santos JM, Dalmau MJ, Bueno M. Cirurg&#237;a card&#237;aca en el anciano: comparaci&#243;n de resultados a medio plazo entre octogenarios y ancianos de 75 a 79 a&#241;os. Rev Esp Cardiol. 2008; 61 (6): 579-88.</p>
      <p>14. Peterson ED, Cowper PA, Jollis JG, Bebchuk JD, DeLong ER, Muhlbaier LH, et al. Outcomes of coronary artery bypass graft surgery in 24461 patients aged 80 years or older. Circulation. 1995; 92 (Suppl II): II-85-II91.</p>
      <p>15. Almeida RMS, Lima Jr JD, Martins JF, Loures DRR. Revasculariza&#231;&#227;o do mioc&#225;rdio em pacientes ap&#243;s a oitava d&#233;cada de vida. Rev Bras Cir Cardiovasc. 2002; 17 (2): 8-14.</p>
      <p>16. Nagpal AD, Bhatnagar G, Cutrara CA, Ahmed SM, McKenzie N, Quantz M, et al. Early outcomes of coronary artery bypass with and without cardiopulmonary bypass in octogenarians. Can J Cardiol. 2006; 22 (10): 849-53.</p>
      <p>17. Li Y, Zheng Z, Hu S. Early and long-term outcomes in the elderly: comparison between off-pump and on-pump techniques in 1191 patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2008; 136: 657-64.</p>
      <p>18. Jones RH. The year in cardiovascular surgery. J Am Coll Cardiol. 2008; 51 (17): 1707-18.</p>
      <p>19. Tyszka AL, Fucuda LS. O uso da art&#233;ria tor&#225;cica interna no idoso: indica&#231;&#245;es e resultados imediatos. Rev Bras Cir Cardiovasc. 2001; 16 (4): 269-74.</p>
      <p>20. Instituto Brasileiro de Geografia e Estat&#237;stica (IBGE). Expectativa de vida da popula&#231;&#227;o brasileira. [Acesso em 2008 dez 10]. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://www.ibge.gov.br">http://www.ibge.gov.br</ext-link> </p>
      <p>21. Stoica SC, Cafferty F, Kitcat J, Baskett RJF, Goddard M, Sharples LD, et al. Octogenarians undergoing cardiac surgery outlive their peers: a case for early referral. Heart. 2006; 92: 503-6.</p>
      <p>22. Sociedade Brasileira de Cardiologia. Diretrizes da cirurgia de revasculariza&#231;&#227;o mioc&#225;rdica. Arq Bras Cardiol. 2004; 82 (supl 5): 1-20.</p>
      <p>
        <fn id="end-body2" fn-type="corresp">
          <label>
            <bold>Correspondencia:</bold>
          </label>
          <p> Renato A. K. Kalil</p>
          <p> Av. Princesa Isabel, 370 - Santana</p>
          <p> 90.620-001 - Porto Alegre,RS - Brasil</p>
          <p> E-mail: </p>
          <p><email xlink:href="kalil.pesquisa@cardiologia.org.br">kalil.pesquisa@cardiologia.org.br</email>, </p>
          <p>
            <email xlink:href="fpivatto@gmail.com">fpivatto@gmail.com</email>
          </p>
        </fn>
      </p>
      <p>Art&#237;culo recibido el 05/11/08; revisado recibido el 06/08/09; aceptado el 25/09/09.</p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Morbimortality in octogenarian patients submitted to coronary artery bypass graft surgery</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Given the progressive increase in longevity and the need of an increasingly elderly population to undergo myocardial revascularization surgery (MRS), it becomes necessary to know its risks and benefits. OBJECTIVE: To evaluate the in-hospital morbimortality of patients aged 80 and older submitted to MRS and identify its predictor variables. METHODS: A total of 140 consecutive cases were studied between January 2002 and December 2007. The patients' mean age was 82.5 &#177; 2.2 years (range: 80-89) and 55.7% were males. In the sample,72.9% had arterial hypertension, 26.4% had diabetes, 65.7% presented severe lesion in three or more vessels and 28.6% presented a severe lesion in the left coronary trunk. An associated surgery was present in 35.7% of the cases, with aortic valve in 26.4% and mitral valve in 5.6%. RESULTS: The mortality rate was 14.3% (isolated MRS 10.0% vs 22.0% with associated procedure; p = 0.091) and the morbidity was 37.9% (isolated MRS 34.4% vs 44.0% with associated procedure; p = 0.35). The most frequent complications were low cardiac output (27.9%), renal dysfunction (10.0%) and prolonged ventilatory support (9.6%). At the bivariate analysis, the most important mortality predictors were sepsis (RR 10.2; 95%CI: 6.10-17.7), previous MRS (RR 8.06; 95%CI: 5.16-12.6), postoperative low cardiac output (RR 7.77; 95%CI: 3.03-19.9) and postoperative renal dysfunction (RR 7.36; 95%CI: 3.71-14.6). The morbidity predictors were extracorporeal circulation time &gt; 120 min. (RR: 2.34; 95%CI: 1.62-3.38) and time of ischemia &gt; 90 min. (RR: 2.29 95%CI: 1.56-3.37). CONCLUSION: The MRS in octogenarians is associated with a higher morbimortality when compared to younger patients, which, however, does not prevent the procedure if the indication is justified by clinical condition.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Myocardial revascularization surgery</kwd>
        <kwd>mortality</kwd>
        <kwd>morbidity</kwd>
        <kwd>80-year-old elderly and older</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="enda-body3">
          <label>
            <bold>Morbimortality in octogenarian patients submitted to coronary artery bypass graft surgery</bold>
          </label>
          <p>
            <bold>Fernando Pivatto J&#250;nior<sup>I,II</sup>; Renato A. K. Kalil<sup>I,II</sup>; Altamiro R. Costa<sup>I</sup>; Edemar M. C. Pereira<sup>I,II</sup>; Eduardo Z. Santos<sup>I,II</sup>; Felipe H. Valle<sup>I,II</sup>; Luciano P. Bender<sup>I,II</sup>; Marcelo Trombka<sup>I,II</sup>; Tha&#237;s B. Modkovski<sup>I,II</sup>; Ivo A. Nesralla<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Instituto de Cardiologia do Rio Grande do Sul/FUC - IC-FUC</p>
      <p><sup>II</sup>Universidade Federal de Ci&#234;ncias da Sa&#250;de de Porto Alegre - UFCSPA, Porto Alegre, RS - Brasil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> Given the progressive increase in longevity and the need of an increasingly elderly population to undergo myocardial revascularization surgery (MRS), it becomes necessary to know its risks and benefits.</p>
      <p><bold>OBJECTIVE:</bold> To evaluate the in-hospital morbimortality of patients aged 80 and older submitted to MRS and identify its predictor variables.</p>
      <p><bold>METHODS:</bold> A total of 140 consecutive cases were studied between January 2002 and December 2007. The patients' mean age was 82.5 &#177; 2.2 years (range: 80-89) and 55.7% were males. In the sample,72.9% had arterial hypertension, 26.4% had diabetes, 65.7% presented severe lesion in three or more vessels and 28.6% presented a severe lesion in the left coronary trunk. An associated surgery was present in 35.7% of the cases, with aortic valve in 26.4% and mitral valve in 5.6%.</p>
      <p><bold>RESULTS:</bold> The mortality rate was 14.3% (isolated MRS 10.0% <italic>vs</italic> 22.0% with associated procedure; p = 0.091) and the morbidity was 37.9% (isolated MRS 34.4% <italic>vs</italic> 44.0% with associated procedure; p = 0.35). The most frequent complications were low cardiac output (27.9%), renal dysfunction (10.0%) and prolonged ventilatory support (9.6%). At the bivariate analysis, the most important mortality predictors were sepsis (RR 10.2; 95%CI: 6.10-17.7), previous MRS (RR 8.06; 95%CI: 5.16-12.6), postoperative low cardiac output (RR 7.77; 95%CI: 3.03-19.9) and postoperative renal dysfunction (RR 7.36; 95%CI: 3.71-14.6). The morbidity predictors were extracorporeal circulation time <underline>&gt;</underline> 120 min. (RR: 2.34; 95%CI: 1.62-3.38) and time of ischemia <underline>&gt;</underline> 90 min. (RR: 2.29 95%CI: 1.56-3.37).</p>
      <p><bold>CONCLUSION:</bold> The MRS in octogenarians is associated with a higher morbimortality when compared to younger patients, which, however, does not prevent the procedure if the indication is justified by clinical condition.</p>
      <p><bold>Key words:</bold> Myocardial revascularization surgery/mortality, morbidity, 80-year-old elderly and older.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>In recent years, the elderly population has increased considerably, in developed as well as in developing countries<sup>1</sup>. The Brazilian demographic data have shown an evident increase in the elderly population, with estimates predicting that Brazil will have the sixth world's elderly population by 2025<sup>2</sup>. </p>
      <p>Cardiovascular disease is extremely prevalent at this age range, with approximately 40% of octogenarians presenting symptomatic cardiovascular disease<sup>3</sup>. </p>
      <p>Several models of epidemiological study have predicted that with the current growth rate of the elderly population, there will be not only an increase in the incidence of coronary artery disease, but also in the total mortality and economic costs, with a probable progressive increase, in the next decades, in the number of elderly patients presenting at the Cardiac Surgery Services<sup>4</sup>.</p>
      <p>Currently, the indication for myocardial revascularization surgery (MRS) in septuagenarians is usual, it is becoming increasingly more common in octogenarians and it is not rare in nonagenarians<sup>5</sup>. It has been broadly reported in the literature that advanced age is a factor correlated with operative mortality and throughout time in myocardial revascularization surgery. For several reasons, it can be considered a high-risk factor in major surgical procedures, especially cardiac surgeries<sup>4</sup>. </p>
      <p>The operative mortality rate in patients aged 70 years or older varied from 5-20% in the last 20 years in isolated MRS, with a mean of 8.9%<sup>6</sup>. The ACC/AHA guidelines report a mortality rate of 5.28% in patients older than 75 years and 8.38% in those older than 80 years<sup>6</sup>. </p>
      <p>The objective of the present study was to evaluate the in-hospital morbimortality of octogenarian patients submitted to MRS and, secondarily, to identify pre, trans and postoperative variables that constitute the morbidity and/or mortality predictors. </p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>This retrospective study included all consecutive patients aged 80 years or older submitted to myocardial revascularization surgery from January 2002 to December 2007 at the Institute of Cardiology of Rio Grande do Sul. The variables included in the present study are shown in <xref ref-type="table" rid="tab1-body3">Table 1</xref>. </p>
      <table-wrap id="tab1-body3">
        <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt01-en.jpg"/></table-wrap>
      <p>Renal dysfunction, both pre and postoperative, was defined by a serum creatinine level &gt; 2 mg/ml. The heart failure (HF) classification followed the criteria established by the New York Heart Association (NYHA). A coronary lesion was considered severe when it was &gt; 70% in the coronary arteries and 50% in the left coronary trunk. Ejection fraction (EF) was considered low when &lt; 50% and normal when &gt;50%. Low cardiac output was considered for all hemodynamic instability with the need for vasoactive drugs or intra-aortic balloon. Localized neurological or consciousness level alterations for period &gt; 24 hours were defined as cerebrovascular accident. In-hospital mortality was defined as any death occurring during the patient's hospitalization, regardless of its duration. The occurrence of one or more of the following events in the postoperative period was defined as operative morbidity: low cardiac output, use of intra-aortic balloon, sepsis, surgical wound or lower-limb infection, renal dysfunction, cerebrovascular accident, reintervention due to bleeding and time of ventilatory support &gt; 48 hours. </p>
      <p>Considering the retrospective design of the present study, there was an expected loss of data, which were not found in the patients' files. That occurred more often in relation to the following variables: NYHA functional class, ejection fraction and time of extracorporeal circulation (ECC), ischemia and ventilatory support. </p>
      <p>The data were collected directly from patients' files, entered in a database and analyzed using the SPSS 15.0 program package. The descriptive analysis for the qualitative variables was carried out through the distribution of absolute and relative frequencies and through means and standard deviations for the quantitative variables. In order to statistically assess the association between two qualitative variables, the Chi-square or Fisher's exact tests were used when indicated. A level of 5 % was established as the limit for rejection of the null hypothesis. Poisson regression was used to evaluate the association between the risk of mortality and the variables and a 95% confidence interval was also used. Student's <italic>t</italic> test was used to compare the means of the quantitative variables in relation to mortality. Due to the low mortality rate and the presence of several significant variables at Poisson regression analysis, the multivariate analysis was not performed.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>The sample consisted of 140 octogenarian patients, among a total of 4,203 myocardial revascularization surgeries (3.3%). The patients' age varied from 80 to 89 years, with a mean age of 82.5 &#177; 2.2. The characteristics of the studied population are shown in <xref ref-type="table" rid="tab2-body3">Table 2</xref>. </p>
      <table-wrap id="tab2-body3">
        <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt02-en.jpg"/></table-wrap>
      <p>Regarding the surgical data, all procedures were carried out with ECC. The internal thoracic artery was used in 24.3% of the patients, mean ECC time was 85.4 &#177; 28.8 minutes and mean myocardial ischemia time was 58.0 &#177; 22.3 minutes. An associated surgery was performed in 50 (35.7%) patients. The associated procedures are listed in <xref ref-type="table" rid="tab3-body3">Table 3</xref>.</p>
      <table-wrap id="tab3-body3">
        <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt03-en.jpg"/></table-wrap>
      <p>Fifty-three patients (37.9%) presented at least one complication in the postoperative period. In patients submitted to isolated revascularization, the rate of complications was 34.4%, with no statistically significant difference when compared with the group that underwent an associated procedure (44.0%; p = 0.35).</p>
      <p><xref ref-type="table" rid="tab4-body3">Table 4</xref> shows the prevalence of the analyzed morbidity, showing that low cardiac output was the most common complication (27.9%). </p>
      <table-wrap id="tab4-body3">
        <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt04-en.jpg"/></table-wrap>
      <p>The observed hospital mortality was 14.3% (20 patients), being 10.0% in patients submitted to isolated revascularization and 22.0% in the presence of an associated procedure. This difference in the mortality rate was not statistically significant (p = 0.091). Cardiogenic shock was the main cause of death, being responsible for the death of 11 patients (55.0%).</p>
      <p>The risk factors for in-hospital mortality are shown in <xref ref-type="table" rid="aop06910en_a05tab05m-body3">Table 5</xref>. All the other analyzed factors that are absent did not show to be significant at the bivariate analysis.</p>
      <p content-type="asset">
        <table-wrap id="aop06910en_a05tab05m-body3">
          <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt05-en.jpg"/></table-wrap>
      </p>
      <p>Regarding the predictors of morbidity, only prolonged ECC and ischemia time were statistically significant (<xref ref-type="table" rid="aop06910en_a05tab06m-body3">Table 6</xref>). </p>
      <p content-type="asset">
        <table-wrap id="aop06910en_a05tab06m-body3">
          <graphic xlink:href="1678-4170-abc-95-01-0041-00071-gt06-en.jpg"/></table-wrap>
      </p>
      <p>
        <bold>Discuss&#227;o</bold>
      </p>
      <p>The need to decide on the best treatment for coronary artery disease in patients older than 80 years has become increasingly frequent. The aging process promotes the increase of comorbidities, in addition to the higher prevalence of coronary artery disease and its consequences in the elderly<sup>7</sup>. </p>
      <p>The surgical indication in octogenarian patients aims chiefly at symptom relief and good quality of life, as the long-term outcome is limited by the life expectancy at this age range and can also be affected by the onset of age-related diseases in other organs<sup>1</sup>. </p>
      <p>In recent years, the myocardial revascularization surgery (MRS) has been increasingly performed in elderly patients with multi-vessel coronary involvement, left ventricular dysfunction and other associated chronic-degenerative diseases. </p>
      <p>The characteristics of this population demonstrate such peculiarities, considering that 65.7% of the patients had severe three-vessel lesion, 26.4% had diabetes and 72.9% had hypertension - frequencies that were similar to data found in the literature<sup>8-10</sup>. Such fact represents an important characteristic of this population, which contributes to its increased surgical risk. </p>
      <p>The combination of more advanced coronary disease and worse comorbidities leads to an increased rate of fatal and nonfatal complications, with higher rates of intra or postoperative myocardial infarction, low cardiac output, cerebrovascular accident, gastrointestinal complications, surgical wound infection, kidney failure and use of intra-aortic balloon<sup>6</sup>. In the present study, the most frequent complication was the low cardiac output (27.9%), as seen in other series<sup>4,11</sup>. </p>
      <p>The in-hospital mortality rate of 14.3% in this series is in agreement with the literature. During the same period of this study, 3,530 isolated revascularization surgeries were carried out at the Institute of Cardiology, with a global in-hospital mortality of 3.7% and 673 revascularizations with associated surgeries, of which mortality was 10.3%. The difference between the mortality rates in isolated procedures (10.0%) and when there is an associated surgical procedure (22.0%) is important, as it is known that the concomitant surgical procedure is relevant, considering that the associated surgical procedure increases the risk of mortality. Igl&#233;zias et al<sup>12</sup> demonstrated an increase of in-hospital mortality of 25%, with a statistically significant difference (p = 0.002) in the group submitted to the isolated surgical procedure, different from what was observed in the present study.. </p>
      <p>L&#243;pez-Rodr&#237;guez et al<sup>13</sup>, in a recent analysis of 140 octogenarians submitted to cardiac surgery, observed a mortality rate of 8.3% in isolated surgeries and 21.4% with associated surgeries; in this study, the ECC was not used by 25% of the patients. Peterson et al<sup>14</sup> have carried out the largest study with octogenarian patients to date, studying 24,461 patients submitted to the isolated surgery, with an in-hospital mortality of 11.5%. </p>
      <p> Several groups have reported on the results of MRS in elderly patients, as it is a particular group of patients, mainly related to associations with other preoperative diseases and the complications that can appear after the procedure<sup>15</sup>. However, to date, there have been few national studies that assessed octogenarian patients and that is the contribution of the present study. </p>
      <p>Igl&#233;zias et al<sup>4</sup> analyzed 361 patients aged <underline>&gt;</underline> 70 years (mean age = 73.9 &#177; 3.3 years) submitted to isolated MRS and reported a 30-day mortality of 9.1%. This same group analyzed, in another study<sup>11</sup>, 100 patients submitted to isolated MRS, also aged <underline>&gt;</underline> 70 years; 50% of the patients were submitted to the surgical procedure with extracorporeal circulation (ECC) and the other half, without ECC. Both groups presented a mean age &gt; 75 years. The 30-day survival was 92% for those submitted to surgery with ECC and 96% for those without ECC, with no statistically significant difference. </p>
      <p>Regarding the surgical procedures of the present study, as described before, they were all carried out with ECC. The benefits of performing off-pump cardiac surgeries in elderly patients have been the subject of debate for some time. A recent article, of which proposal was to analyze the use of off-pump MRS in octogenarian patients in comparison to the conventional surgery, did not demonstrate a significant difference in mortality between these two groups (conventional 6.7%, off-pump 3.1%; p = 0.22)<sup>16</sup>. Li et al<sup>17</sup>, in an analysis of 1,191 patients aged &gt; 65 years, observed that the off-pump MRS was associated with more favorable early outcomes, which, however, did not persist at long-term follow-up, with the traditional surgery being associated with better middle and long-term outcomes. This observation was ratified in a recent review article, which observed that current evidence suggests that off-pump MRS can offer lower perioperative morbidity, but at the cost of a lower long-term effectiveness<sup>18</sup>. The internal thoracic artery (ITA) is the best graft for myocardial revascularization regarding long-term patency, free from recurrence of angina and late cardiac events. Due to the fact that the apparent benefit of using the ITA has been more emphasized regarding late patency and survival outcomes, many surgeons avoided using it in elderly patients, presuming that no substantial benefit was observed in this population<sup>19</sup>. In Brazil, the current life expectancy is 72.4 years; however, individuals who reach the eighth decade of life live on average 9.4 more years<sup>20</sup>. Therefore, more important than the global life expectancy of the general population is the life expectancy for those individuals who reach their eighth decade. Regarding the survival of octogenarian patients submitted to MRS, studies have demonstrated that those submitted to the isolated surgery have a similar<sup>14</sup> or higher survival<sup>21</sup> than that of the general population. Thus, the nonuse of the ITA in elderly patients, due to the presumed loss of importance of its late patency, cannot be viewed as a correct approach. </p>
      <p>The low rate of the ITA use in the present study (24.3%) is justified by the its retrospective nature, which demonstrated the reality of a hospital throughout a long period of time, where the opinion on the use of this graft at the studied age range has changed, with the ITA being currently preferred by most surgeons, even in octogenarian patients.</p>
      <p>The predictors of in-hospital mortality shown in <xref ref-type="table" rid="tab4-body3">Table 4</xref> are similar to those found in other studies with elderly patients. The most significant predictors were sepsis, previous MRS, postoperative low cardiac output and pre and postoperative renal dysfunction. It is worth mentioning again the limitation of the present study, considering that, due to the small sample size and the large number of predictor variables at the bivariate analysis, the multivariate analysis was not performed, which could have provided independent predictor indications of in-hospital mortality. </p>
      <p>An analysis carried out by L&#243;pez-Rodr&#237;guez et al<sup>13</sup> of 589 patients aged &gt; 75 years submitted to cardiac surgery showed that prolonged ECC time, i.e., &gt; 120 minutes, is an independent predictor of postoperative morbidity. In the present study, this variable showed to be a predictor at the bivariate analysis, as well as the prolonged time of ischemia.</p>
      <p>According to the Guidelines of the Brazilian Society of Cardiology<sup>22</sup>, age must not be a contraindication for surgery and it is important to assess the patient's actual age <italic>vs</italic> apparent age, general status and physical and intellectual capacity. According to the ACC/AHA guidelines<sup>6</sup>, the patient and the physician must explore together the potential benefits of quality of life improvement, observing the risks of the procedure in comparison with an alternative therapy, also taking into account the patient's basal functional capacity and wishes. </p>
      <p>Age alone must not be a contraindication for the myocardial revascularization surgery, if we consider that the benefits can overcome the risks of the procedure in the long term. </p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>The myocardial revascularization surgery in octogenarian patients is associated with a higher morbimortality when compared to younger patients, which, however, does not prevent the procedure, when indicated by the clinical condition. </p>
      <p>The most frequent complications were low cardiac output, renal dysfunction and prolonged ventilatory support. The most important predictors of mortality were sepsis, previous MRS, postoperative low cardiac output and postoperative renal dysfunction. As for the morbidity, its main predictors were ECC time <underline>&gt;</underline> 120 min and ischemia time <underline>&gt;</underline> 90 min. Thus, the surgical indication must be carefully assessed and individualized, taking into the account the patient's age and general status, life expectancy, probability of return to social life, the coronary lesion location and severity, the extension of myocardial ischemia, symptom intensity, presence of comorbidities, the surgical team's experience and the comparative results with other forms of pharmacological treatment and percutaneous angioplasty. </p>
      <p>
        <bold>Acknowledgments</bold>
      </p>
      <p>We thank Dr. Guaracy Fernandes Teixeira Filho, Dr. Paulo Roberto Prates and Dr. Jo&#227;o Ricardo Michielin Sant&#180;Anna, members of the Cardiovascular Surgical team of IC-FUC.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
